Correlation Between Adagene and Aerovate Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Adagene and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adagene and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adagene and Aerovate Therapeutics, you can compare the effects of market volatilities on Adagene and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adagene with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adagene and Aerovate Therapeutics.

Diversification Opportunities for Adagene and Aerovate Therapeutics

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between Adagene and Aerovate is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Adagene and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Adagene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adagene are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Adagene i.e., Adagene and Aerovate Therapeutics go up and down completely randomly.

Pair Corralation between Adagene and Aerovate Therapeutics

Given the investment horizon of 90 days Adagene is expected to under-perform the Aerovate Therapeutics. In addition to that, Adagene is 1.85 times more volatile than Aerovate Therapeutics. It trades about -0.11 of its total potential returns per unit of risk. Aerovate Therapeutics is currently generating about 0.06 per unit of volatility. If you would invest  253.00  in Aerovate Therapeutics on October 20, 2024 and sell it today you would earn a total of  5.00  from holding Aerovate Therapeutics or generate 1.98% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.0%
ValuesDaily Returns

Adagene  vs.  Aerovate Therapeutics

 Performance 
       Timeline  
Adagene 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Adagene has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Aerovate Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Adagene and Aerovate Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Adagene and Aerovate Therapeutics

The main advantage of trading using opposite Adagene and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adagene position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.
The idea behind Adagene and Aerovate Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges